로딩 중…
지수 로딩 중…
DuChemBIO Co.,Ltd.
176750· KOSDAQ· Health Care· Health Care Equipment & Services
₩6,290-4.84%
2026-06-19
Price Chart
DuChemBIO Co.,Ltd.-41.71%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 179.19B KRW |
| Revenue | 39.82B KRW |
| Net Income | 3.81B KRW |
| Total Assets | 77.20B KRW |
| Net Assets | 50.11B KRW |
| Employees | 141 |
| Value | |
| P/E | 47.03x |
| P/B | 3.58x |
| PEG | 0.36x |
| P/S | 4.50x |
| EV/EBITDA | 47.12x |
| FCF Yield | 5.06% |
| Profitability | |
| ROE | 7.60% |
| ROA | 4.94% |
| Op. Margin | 8.97% |
| Revenue Growth | 14.72% |
| Earnings Growth | 130.99% |
| Financial Health | |
| Debt Ratio | 154.06% |
| Total Debt | 5.94B KRW |
| FCF | 9.07B KRW |
| Cash | 16.82B KRW |
| Current Ratio | 1.69x |
| Net Debt/EBITDA | -3.05x |
| Performance | |
| 1Y Return | -41.71% |
| 1M Return | -18.63% |
| From 52W High | -50.74% |
| 1Y MDD | -50.77% |
| Trading | |
| Volume | 31,382 shares |
| Foreign Own. | 0.96% |
| Per Share | |
| EPS | 245 KRW |
| BPS | 1,768 KRW |
Company Info
DuChemBio was established in 2002 for the development, manufacturing, and sales of radiopharmaceuticals for cancer and brain disease diagnosis and treatment, completing its KOSDAQ transfer listing in 2024. The company holds the largest number of PET-CT pharmaceuticals in Korea and operates 12 GMP-certified manufacturing facilities, achieving the top market share in major product categories. With a "First-in-Class" strategy for diagnostics and "Best-in-Class" for therapeutics, DuChemBio is striving to become a specialized radiopharmaceutical platform company in Asia. DuChemBio was established in 2002 and is headquartered in Mapo-gu, Seoul.